| scholarly article | Q13442814 |
| P50 | author | Nora Volkow | Q457967 |
| P2093 | author name string | A Thomas McLellan | |
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | opioid use disorder | Q1639178 |
| opioid | Q427523 | ||
| chronic pain | Q1088113 | ||
| P304 | page(s) | 1253-63 | |
| P577 | publication date | 2016-03-31 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies | |
| P478 | volume | 374 |
| Q41305455 | 2017 ASTHO President's Challenge: Public Health Approaches to Preventing Substance Misuse and Addiction |
| Q31162537 | A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care |
| Q58597645 | A Cross-sectional Survey Using Clinical Vignettes to Examine Overdose Risk Assessment and Willingness to Prescribe Naloxone |
| Q53819121 | A Genetically Encoded Biosensor Reveals Location Bias of Opioid Drug Action. |
| Q55021845 | A Mobile Health Intervention to Reduce Pain and Improve Health (MORPH) in Older Adults With Obesity: Protocol for the MORPH Trial. |
| Q44339136 | A Novel Chronic Opioid Monitoring Tool to Assess Prescription Drug Steady State Levels in Oral Fluid |
| Q88961897 | A Review of the Burden of Trauma Pain in Emergency Settings in Europe |
| Q47253367 | A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse. |
| Q96304210 | A Step Towards a Better Understanding of Pain Phenotypes: Latent Class Analysis in Chronic Pain Patients Receiving Multimodal Inpatient Treatment |
| Q60650856 | A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates |
| Q90575892 | A bivalent compound targeting CCR5 and the mu opioid receptor treats inflammatory arthritis pain in mice without inducing pharmacologic tolerance |
| Q64076165 | A novel neuromodulation strategy to enhance the prefrontal control to treat pain |
| Q37264264 | A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates |
| Q91850771 | A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment |
| Q38710339 | A retrospective review of unintentional opioid overdose risk and mitigating factors among acutely injured trauma patients. |
| Q91824398 | Access to Primary Care Clinics for Patients With Chronic Pain Receiving Opioids |
| Q47274091 | Affective dysregulation predicts incident nonmedical prescription analgesic use among college students |
| Q30248638 | Alcohol and Opioid Use Disorder in Older Adults: Neglected and Treatable Illnesses |
| Q44349264 | All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population |
| Q46227940 | Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report |
| Q37590161 | Allostatic Mechanisms of Opioid Tolerance Beyond Desensitization and Downregulation |
| Q50026107 | Altered signaling in the descending pain modulatory system after short-term infusion of the μ-opioid agonist remifentanil. |
| Q52762460 | Alternative analgesics: New drugs for pain seek to improve on ketamine's benefits. |
| Q64938567 | An exploration of ontology-based EMR data abstraction for diabetic kidney disease prediction. |
| Q49689310 | Anesthetic implications of recreational drug use. |
| Q92681147 | Anhedonia in chronic pain and prescription opioid misuse |
| Q38615910 | Anti-nociceptive action of peripheral mu-opioid receptors by G-beta-gamma protein-mediated inhibition of TRPM3 channels. |
| Q92525773 | Anxiety sensitivity and opioid misuse among opioid-using adults with chronic pain |
| Q89771270 | Anxiety sensitivity and opioid misuse and dependence among trauma-exposed adults with chronic pain |
| Q91594587 | Apparent Effects of Opioid Use on Neural Responses to Reward in Chronic Pain |
| Q96304206 | Are Opioids Needed to Treat Chronic Low Back Pain? A Review of Treatment Options and Analgesics in Development |
| Q90253741 | Aroma-triggered pain relief |
| Q64236040 | Assessing treatment and monitoring of musculoskeletal conditions using opioid versus nonopioid therapy: A cross-sectional study |
| Q60955319 | Association of Early Physical Therapy With Long-term Opioid Use Among Opioid-Naive Patients With Musculoskeletal Pain |
| Q47330548 | Association of Household Opioid Availability and Prescription Opioid Initiation Among Household Members |
| Q90355530 | Association of Lowering Default Pill Counts in Electronic Medical Record Systems With Postoperative Opioid Prescribing |
| Q88250253 | Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees |
| Q90297267 | Association of Opioid Use With Pain and Satisfaction After Dental Extraction |
| Q44351006 | Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study |
| Q91844073 | Autonomic and affective mediators of the relationship between mindfulness and opioid craving among chronic pain patients |
| Q90259962 | Balancing opioid analgesia with the risk of nonmedical opioid use in patients with cancer |
| Q43075742 | Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics. |
| Q92922418 | Battlefield Acupuncture and Physical Therapy Versus Physical Therapy Alone After Shoulder Surgery |
| Q30396711 | Benzodiazepine Dependence among Young Adult Participants in the Club Scene Who Use Drugs |
| Q64967561 | Beware of Undertow: Opioid Drugs Generate Additional Waves of Intracellular Signaling. |
| Q91789368 | Brain Metabolism in Rats with Neuropathic Pain Induced by Brachial Plexus Avulsion Injury and Treated via Electroacupuncture |
| Q39360773 | Breaking barriers to novel analgesic drug development |
| Q92838156 | Care for low back pain: can health systems deliver? |
| Q90304129 | Challenges of differential placebo effects in contemporary medicine: The example of brain stimulation |
| Q42373815 | Changes in pain and concurrent pain medication use following compounded topical analgesic treatment for chronic pain: 3- and 6-month follow-up results from the prospective, observational Optimizing Patient Experience and Response to Topical Analgesi |
| Q99616612 | Characterization of the intergenerational impact of in utero and postnatal oxycodone exposure |
| Q43075740 | Chronic Opioid Use After Surgery: Implications for Perioperative Management in the Face of the Opioid Epidemic |
| Q59355091 | Chronic Pain Opioid-Maintained Patients Receive Less Analgesic Opioid Prescriptions |
| Q57029286 | Chronic linaclotide treatment reduces colitis-induced neuroplasticity and reverses persistent bladder dysfunction |
| Q38853123 | Codeine use, dependence and help-seeking behaviour in the UK and Ireland: an online cross-sectional survey. |
| Q53406290 | Comparative Effect of Collaborative Care, Pain Medication, and Duloxetine in the Treatment of Major Depressive Disorder and Comorbid (Sub)Chronic Pain: Results of an Exploratory Randomized, Placebo-Controlled, Multicenter Trial (CC:PAINDIP). |
| Q42081917 | Confronting the opioid epidemic through publication, promotion, and dissemination of evidence-based addiction scholarship |
| Q39304494 | Corticolimbic circuitry in the modulation of chronic pain and substance abuse |
| Q90128968 | Deconstructing biomarkers for chronic pain: context- and hypothesis-dependent biomarker types in relation to chronic pain |
| Q36131787 | Dependence to legally prescribed opioid analgesics in a university hospital in Medellin-Colombia: an observational study |
| Q38861751 | Depression of home cage wheel running is an objective measure of spontaneous morphine withdrawal in rats with and without persistent pain. |
| Q92535035 | Developing Modern Pain Therapies |
| Q90301848 | Diverse diagnostic profiles associated with prescription opioid use disorder in a nationwide sample: One crisis, multiple needs |
| Q59795503 | Drug Addiction: From Neuroscience to Ethics |
| Q90329436 | Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year |
| Q36202360 | Durations of Opioid, Nonopioid Drug, and Behavioral Clinical Trials for Chronic Pain: Adequate or Inadequate? |
| Q90583672 | EMR implementation of default opioid prescription quantities |
| Q57144891 | Early adolescent nicotine exposure affects later-life hippocampal mu-opioid receptors activity and morphine reward but not physical dependence in male mice |
| Q39325770 | Effect of Educating the Primary Care Physician About Headache to Help Reduce "Trivial" Referrals and Improve the Number and Quality of "Substantial" Referrals that Truly Need Subspecialty Headache Medicine Care |
| Q92456766 | Effect of pill mill laws on opioid overdose deaths in Ohio & Tennessee: A mixed-methods case study |
| Q40485841 | Effective Canadian policy to reduce harms from prescription opioids: learning from past failures. |
| Q88503022 | Effects of human SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of acetaminophen and opioid drugs by the cytosolic sulfotransferase SULT1A3 |
| Q91938833 | Emerging Trend in the Pharmacotherapy of Osteoarthritis |
| Q55487569 | Emotion dysregulation as a transdiagnostic mechanism of opioid misuse and suicidality among chronic pain patients. |
| Q88933804 | Endogenous and Exogenous Opioids in Pain |
| Q89450936 | Evaluation of opioid discontinuation after non-orthopaedic surgery among chronic opioid users: a population-based cohort study |
| Q57815951 | Fact or fiction: the truth behind the doctors company claims regarding licit and illicit opioids |
| Q47265813 | Fatal Overdoses of Opioids in Israel 2005-2014. |
| Q49567599 | Federal and State Policy Efforts to Address Maternal Opioid Misuse: Gaps and Challenges |
| Q99239686 | Fentalogues |
| Q50066450 | Fentanyl Induces Rapid Onset Hyperalgesic Priming: Type I at Peripheral and Type II at Central Nociceptor Terminals |
| Q64109200 | Frequency and Risk Factors for Prolonged Opioid Prescriptions After Surgery for Brachial Plexus Injury |
| Q38923769 | Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic |
| Q65000357 | From Opioid Pain Management to Opioid Crisis in the USA: How Can Public-Private Partnerships Help? |
| Q46495125 | Frustrated Patients and Fearful Physicians |
| Q55317223 | Functional Divergence of Delta and Mu Opioid Receptor Organization in CNS Pain Circuits. |
| Q69497299 | Genetic behavioral screen identifies an orphan anti-opioid system |
| Q89537797 | Healthcare Resource Use and Cost: The Impact of Adopting an Abuse-Deterrent Formulation of Extended Release Morphine |
| Q37416000 | Healthcare system-wide implementation of opioid-safety guideline recommendations: the case of urine drug screening and opioid-patient suicide- and overdose-related events in the Veterans Health Administration |
| Q38643889 | Heroin use onset among nonmedical prescription opioid users in the club scene |
| Q47105347 | Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant |
| Q40955120 | Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment. |
| Q38975567 | Hydrocodone Bitartrate ER (Hysingla® ER): A Review in Chronic Pain |
| Q44351256 | Impact of Cystectomy with Urinary Diversion upon Tracked Receipt of Opioid Prescriptions among Patients with Interstitial Cystitis/Bladder Pain Syndrome |
| Q40043545 | Impact of human CA8 on thermal antinociception in relation to morphine equivalence in mice |
| Q90185275 | Improved efficacy, tolerance, safety and abuse liability profile of the combination CR4056-morphine over morphine alone in rodent models |
| Q38373836 | Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Clinical Trial |
| Q43075560 | Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients |
| Q88766348 | Interactions between kappa and mu opioid receptor agonists: effects of the ratio of drugs in mixtures |
| Q90393909 | Intrasubject repeatability of in vivo intervertebral motion parameters using quantitative fluoroscopy |
| Q57456146 | K2P channels: Emerging targets for novel analgesic drugs |
| Q89580792 | Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic |
| Q89342051 | Level of readiness of chronic pain patients to practise active self-care |
| Q92192403 | Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders |
| Q55305665 | Linking opioid-induced hyperalgesia and withdrawal-associated injury site pain: a case report. |
| Q90224546 | Long-Term Trends in Postoperative Opioid Prescribing, 1994 to 2014 |
| Q88992128 | Long-acting opioid initiation in US nursing homes |
| Q91562913 | Long-term opioid use in curative-intent radiotherapy: One-Year outcomes in head/neck cancer patients |
| Q37629809 | Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia |
| Q33576918 | Low back pain in older adults: risk factors, management options and future directions |
| Q38852222 | Management of Pain Associated with Selected Conditions in Dermatology |
| Q43075640 | Measurement of Chronic Pain and Opioid Use Evaluation in Community-Based Persons with Serious Illnesses |
| Q90158308 | Measuring Opioid Withdrawal in a Phase 3 Study of a New Analgesic, NKTR-181 (Oxycodegol), in Patients with Moderate to Severe Chronic Low Back Pain |
| Q99630771 | Mechanisms and Clinical Features of Co-occurring Opioid and Nicotine Use |
| Q90301869 | Men's misuse of prescription opioids from early to middle adulthood: An examination of developmental and concurrent prediction models |
| Q92824034 | Morphine tolerance is attenuated in germfree mice and reversed by probiotics, implicating the role of gut microbiome |
| Q50207918 | Moving Forward with Physical Activity: Self-Management of Chronic Pain among Women |
| Q98224518 | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective |
| Q64998162 | Naloxone interventions in opioid overdoses: a systematic review protocol. |
| Q97423657 | Nanotechnology in Chronic Pain Relief |
| Q30234866 | Narcotic bowel syndrome. |
| Q47628080 | National trends in long-term use of prescription opioids |
| Q92699061 | Network Alterations in Comorbid Chronic Pain and Opioid Addiction: An Exploratory Approach |
| Q26742048 | Neurobiology of opioid dependence in creating addiction vulnerability |
| Q33602197 | Neuroinflammation-a co-occurring phenomenon linking chronic pain and opioid dependence |
| Q92444080 | New Engineered-Botulinum Toxins Inhibit the Release of Pain-Related Mediators |
| Q96615079 | New directions in the treatment of opioid withdrawal |
| Q44341027 | New opioid prescribing guidelines released in the US: what impact will they have in the care of older patients with persistent pain? |
| Q93081359 | Opioid Addiction, Genetic Susceptibility, and Medical Treatments: A Review |
| Q50281664 | Opioid Overdose Education for Individuals Prescribed Opioids for Pain Management: Randomized Comparison of Two Computer-Based Interventions. |
| Q44343920 | Opioid Prescribing Patterns and Costs in a Large Group of Patients in Colombia. |
| Q41376301 | Opioid Prescribing Practices and Training Needs of Québec Family Physicians for Chronic Noncancer Pain |
| Q49583253 | Opioid Prescribing: What Are the Numbers? |
| Q89855667 | Opioid Utilization in Geriatric Patients After Operation for Degenerative Spine Disease |
| Q89207660 | Opioid receptors: drivers to addiction? |
| Q61446103 | Opioid use and misuse in ulcerative colitis |
| Q52676810 | Opioid use and stigma: The role of gender, language and precipitating events. |
| Q92527205 | Opioid use disorder |
| Q90443281 | Opioid-Induced Tolerance and Hyperalgesia |
| Q39192669 | Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis. |
| Q96134915 | Opioid-induced Somatic Activation: Prevalence in a Population of Patients With Chronic Pain |
| Q90070111 | Opioids and Their Endocrine Effects: A Systematic Review and Meta-analysis |
| Q60708787 | Opioids for Chronic Noncancer Pain |
| Q89946431 | Opioids: keeping the good, eliminating the bad |
| Q90263658 | Optimal control of diffusion processes pertaining to an opioid epidemic dynamical model with random perturbations |
| Q64062465 | Osteoarthritis- a systematic review of long-term safety implications for osteoarthritis of the knee |
| Q93090641 | Pain And Opioid Systems, Implications In The Opioid Epidemic |
| Q64289493 | Pain Management Associated with Total Joint Arthroplasty: A Primer |
| Q90132672 | Pain catastrophizing as a predictor of suicidal ideation in chronic pain patients with an opiate prescription |
| Q42370485 | Pain in the management of opioid use disorder |
| Q90301853 | Perceived health, medical, and psychiatric conditions in individual and dual-use of marijuana and nonprescription opioids |
| Q41989044 | Pharmacists' Role in Opioid Safety: A Focus Group Investigation. |
| Q55115546 | Placebo Analgesia in Rodents: Current and Future Research. |
| Q49990577 | Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study |
| Q90354037 | Practical approach to a patient with chronic pain of uncertain etiology in primary care |
| Q57486610 | Preclinical and Clinical Pharmacology of Hydrocodone for Chronic Pain: A Mini Review |
| Q92642185 | Predicting high-risk opioid prescriptions before they are given |
| Q90209743 | Predictors of Postdeployment Prescription Opioid Receipt and Long-term Prescription Opioid Utilization Among Army Active Duty Soldiers |
| Q89330810 | Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis |
| Q64117916 | Prescribing patterns of tramadol in adults in IMS® primary care databases in France and Germany between 1 January 2006 and 30 June 2016 |
| Q61047815 | Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit |
| Q90250825 | Prevalence and patterns of opioid misuse and opioid use disorder among primary care patients who use tobacco |
| Q38617900 | Prevalence of pain and its socio-demographic and clinical correlates among heroin-dependent patients receiving methadone maintenance treatment |
| Q50417254 | Protocol: mixed-methods study to evaluate implementation, enforcement, and outcomes of U.S. state laws intended to curb high-risk opioid prescribing. |
| Q55281652 | Provider preferences for postoperative analgesia in obese and non-obese patients undergoing ambulatory surgery. |
| Q47549615 | Psychiatric Aspects of Acute Porphyria: a Comprehensive Review. |
| Q52316080 | Psychiatry and Pain Management: at the Intersection of Chronic Pain and Mental Health. |
| Q46507836 | Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations |
| Q49968187 | Reduction of opioid use and improvement in chronic pain in opioid-experienced patients after topical analgesic treatment: an exploratory analysis |
| Q90567570 | Regulatory Policies for Alcohol, other Psychoactive Substances and Addictive Behaviours: The Role of Level of Use and Potency. A Systematic Review |
| Q50100164 | Relative Bioavailability, Intranasal Abuse Potential, and Safety of Benzhydrocodone/Acetaminophen Compared with Hydrocodone Bitartrate/Acetaminophen in Recreational Drug Abusers |
| Q92948413 | Repurposing of Tranilast for Potential Neuropathic Pain Treatment by Inhibition of Sepiapterin Reductase in the BH4 Pathway |
| Q92225515 | Risk Assessment and Monitoring of Patients with Cancer Receiving Opioid Therapy |
| Q38648846 | Risk markers for fatal and non-fatal prescription drug overdose: a meta-analysis |
| Q88438593 | STRATEGIES TO ENHANCE RECRUITMENT METHODS IN PHANTOM LIMB PAIN CLINICAL TRIALS |
| Q30839446 | Secular trends in opioid prescribing in the USA. |
| Q89446695 | Selective Adenylyl Cyclase Type 1 Inhibitors as Potential Opioid Alternatives For Chronic Pain |
| Q49814346 | Sex differences in antinociceptive response to Δ-9-tetrahydrocannabinol and CP 55,940 in the mouse formalin test. |
| Q58608368 | Short- and Long-term Opioid Use in Patients with Oral and Oropharynx Cancer |
| Q44350642 | Short-Acting Opioids Are Associated with Comparable Analgesia to Long-Acting Opioids in Patients with Chronic Osteoarthritis with a Reduced Opioid Equivalence Dosing |
| Q51415068 | Solution to Detect, Classify, and Report Illicit Online Marketing and Sales of Controlled Substances via Twitter: Using Machine Learning and Web Forensics to Combat Digital Opioid Access. |
| Q42358357 | Spinal manipulative therapy for low back pain-time for an update |
| Q38638627 | Strategies to Identify and Reduce Opioid Misuse Among Patients with Gastrointestinal Disorders: A Systematic Scoping Review |
| Q48141734 | Structure-Activity Relationship Studies on a Series of 3α-[Bis(4-fluorophenyl)methoxy]tropanes and 3α-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use Disorders |
| Q44343990 | Synthesis and Opioid Activity of Tyr1 -ψ[(Z)CF=CH]-Gly2 and Tyr1 -ψ[(S)/(R)-CF3 CH-NH]-Gly2 Leu-enkephalin Fluorinated Peptidomimetics |
| Q60728516 | Synthesis of Enantiopure PZM21: A Biased Agonist of the Mu-Opioid Receptor |
| Q41655660 | Taking adolescent prescription opioid use in context: risk stratification in early mid-life based on medical and nonmedical use. |
| Q90180273 | Taking opioids in times of crisis: Institutional oversight, chronic pain and suffering in an integrated healthcare delivery system in the U.S. |
| Q64999548 | Tapentadol Prolonged Release: A Review in Pain Management. |
| Q91796599 | The Cholinergic System as a Treatment Target for Opioid Use Disorder |
| Q92644109 | The Emerging Perspective of Morphine Tolerance: MicroRNAs |
| Q64077006 | The Four-Cluster Spectrum of Mind-Body Interrelationships: An Integrative Model |
| Q92592658 | The Impact of Preoperative Opioid Use Disorder on Complications and Costs following Primary Total Hip and Knee Arthroplasty |
| Q89939771 | The Modified WHO Analgesic Ladder: Is It Appropriate for Chronic Non-Cancer Pain? |
| Q58107971 | The Paucity of Attention to Narcotics Anonymous in Current Public, Professional, and Policy Responses to Rising Opioid Addiction |
| Q64108951 | The Role of Toxins in the Pursuit for Novel Analgesics |
| Q41996190 | The conundrum of opioid tapering in long-term opioid therapy for chronic pain: A commentary |
| Q47958958 | The future of the international drug control system and national drug prohibitions |
| Q87802259 | The grimace scale reliably assesses chronic pain in a rodent model of trigeminal neuropathic pain |
| Q93113089 | The mitochondrial calcium uniporter contributes to morphine tolerance through pCREB and CPEB1 in rat spinal cord dorsal horn |
| Q90848457 | The nexus of opioids, pain, and addiction: Challenges and solutions |
| Q89746347 | The opioid mortality epidemic in North America: do we understand the supply side dynamics of this unprecedented crisis? |
| Q58806317 | The prevalence and awareness of sleep apnea in patients suffering chronic pain: an assessment using the STOP-Bang sleep apnea questionnaire |
| Q39150974 | Therapy-Related Explants After Spinal Cord Stimulation: Results of an International Retrospective Chart Review Study |
| Q39158635 | Time for nonaddictive relief of pain |
| Q33700472 | Tolerability of Opioid Analgesia for Chronic Pain: A Network Meta-Analysis |
| Q92685504 | Trajectories of pain and anxiety in a longitudinal cohort of adolescent twins |
| Q91706704 | Transcranial Direct Current Stimulation to Improve the Dysfunction of Descending Pain Modulatory System Related to Opioids in Chronic Non-cancer Pain: An Integrative Review of Neurobiology and Meta-Analysis |
| Q38376069 | Treatment utilization among persons with opioid use disorder in the United States. |
| Q51411866 | Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe. |
| Q52944734 | Twitter-Based Detection of Illegal Online Sale of Prescription Opioid. |
| Q40065249 | U.S. Epidemiology of Cannabis Use and Associated Problems |
| Q92515547 | Understanding Buprenorphine for Use in Chronic Pain: Expert Opinion |
| Q90094055 | Unintentional Drug-related Deaths in Cambridgeshire: A Retrospective Observational Study |
| Q64235286 | Use of Prescription Opioids and Initiation of Fatal 2-Vehicle Crashes |
| Q38745880 | Use of prescribed opioids before and after bariatric surgery: prospective evidence from a U.S. multicenter cohort study |
| Q43076011 | Use of strong opioids for chronic pain in osteoarthritis: an insight into the Latin American reality |
| Q88882136 | Ventilatory-depressant effects of opioids alone and in combination with cannabinoids in rhesus monkeys |
| Q91928984 | Virtual reality as a non-pharmacologic analgesic for fasciotomy wound infections in acute compartment syndrome: a case report |
| Q49964255 | Web-Based Cognitive Behavior Therapy for Chronic Pain Patients with Aberrant Drug-Related Behavior: Outcomes from a Randomized Controlled Trial. |
| Q47553788 | Which Point-of-Care Tests Would Be Most Beneficial to Add to Clinical Practice?: Findings From a Survey of 3 Family Medicine Clinics in the United States |
| Q37420079 | Withdrawal-associated injury site pain (WISP): a descriptive case series of an opioid cessation phenomenon |
| Q89538128 | Women's Perspectives On Provider Education Regarding Opioid Use |
| Q38938183 | mPer1 promotes morphine-induced locomotor sensitization and conditioned place preference via histone deacetylase activity |
Search more.